NEW YORK – Patient advocates have surveyed clinicians at cancer centers across Canada to identify gaps in access to biomarker testing and they hope the findings will spur policymakers to develop standardized guidelines and increase funding to make precision oncology more equitable.
Get the full story with
Only $95 for the
first 90 days*
Premium Access gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
You may already have institutional access!
Already a Precision Oncology News or 360Dx or GenomeWeb Premium member?
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.